Clinical trial Recruiting at 1 site Observational Ages 18 and up

Pulse palpation vs arterial blood pressure in circulatory shock

Official title: Association Between Palpable Peripheral Pulses and Arterial Blood Pressure in Patients With Circulatory Shock: An International Prospective Multicenter Observational Cohort Study

Run by Region Stockholm · NCT07609095 · Data updated 2026-11-12

This study tests how well feeling for a pulse at typical sites matches the actual arterial blood pressure in adults with circulatory shock or risk of failure.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment5000 (estimated)
SponsorRegion Stockholm
Government
Locations1 site (Stockholm, Stockholm County)
StatusRecruiting
StartedJune 1, 2026
Main results expectedJune 1, 2031
Study endsDecember 31, 2031
Registry record updatedAugust 18, 2026
Trial IDNCT07609095 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with circulatory shock or impending circulatory failure who are already receiving non-invasive or invasive arterial blood pressure monitoring and for whom pulse palpation can be performed without delaying care.

Probably not a fit

Patients with peripheral vascular conditions preventing reliable palpation or those in whom study procedures would interfere with life-saving treatment may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This international, multicenter, prospective observational study examines the relationship between palpable peripheral pulses (carotid, femoral, and radial) and concurrently measured arterial blood pressure in adults with circulatory shock or impending circulatory failure. Patients already under routine hemodynamic monitoring will have pulse palpation performed as part of standard care, while non-invasive or invasive blood pressure data are collected from their monitoring. The study aims to quantify how pulse presence or absence relates to systolic blood pressure, identify thresholds where pulses are palpable, compare invasive and non-invasive measurements, and explore how factors like vascular disease or vasoactive medications affect palpability. No changes to treatment will be made for the study, and data collection occurs during normal clinical care. Results could improve bedside assessment of circulation in emergency, critical care, and resuscitation settings.

Why it matters

Potential benefit: If successful, the findings could improve quick bedside judgments of circulatory status when a pulse is palpable or not.

How similar studies have gone: Previous small observational work suggested links between palpable pulses and blood pressure, but evidence in diverse, real-world settings remains limited, making this study novel in scale and scope.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Clinical signs of circulatory shock or impending circulatory failure
* Availability of non-invasive and/or invasive arterial blood pressure monitoring
* Pulse palpation possible without interfering with emergency care

Exclusion Criteria:

* Peripheral vascular conditions preventing reliable pulse palpation
* Major extremity amputation affecting assessment sites
* Clinical situations where study procedures interfere with life-saving treatment

Where it's running

  • Region Stockholm, all hospitals
    Stockholm, Stockholm County, Sweden
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.